O. Miyazaki

NK314, a novel topoisomerase II inhibitor, induces rapid DNA double-strand breaks and exhibits superior antitumor effects against tumors resistant to other topoisomerase II inhibitors.

T. Onda, K. Nishikawa, K. Okamoto, 2008, Cancer letters.

Antitumoral efficacy and pharmacokinetic properties of pirarubicin upon hepatic intra-arterial injection in the rabbit V x 2 tumour model.

T. Takeuchi, H. Ekimoto, H. Iguchi, 1995, British Journal of Cancer.

Retroviral reverse transcriptase inhibitory activity in Thai herbs and spices: screening with Moloney murine leukemia viral enzyme.

O. Suthienkul, U. Kositanont, M. Chulasiri, 1993, The Southeast Asian journal of tropical medicine and public health.

Antimyeloma activity of NK012, a micelle‐forming macromolecular prodrug of SN‐38, in an orthotopic model

T. Onda, Y. Miyakawa, T. Morino, 2014, International journal of cancer.